NCT02112188
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 21 Years to 80 Years (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patients must be non-US born & of Chinese descent
Exclusions: 
https://ClinicalTrials.gov/show/NCT02112188